{
  "title": "M21-1, Part V, Subpart iii, Chapter 1, Section F - Other Musculoskeletal Considerations",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014425/M21-1-Part-V-Subpart-iii-Chapter-1-Section-F-Other-Musculoskeletal-Considerations",
  "content": "<-- Previous Section\nNext Section -->\nOverview\nIn This Section\nThis section contains the topic “\nOther Musculoskeletal Considerations\n.”\n1\n.\nOther Musculoskeletal Considerations\nIntroduction\nThis topic contains general guidance on evaluating musculoskeletal conditions, including\nservice connection (SC) for\nfractures\n, and\nosteopenia\nevaluating fibromyalgia\nconsidering conflicting decisions regarding loss of use (LOU) of an extremity\napplying the amputation rule\nnon-service-connected (NSC) amputation eliminating a distal service-connected (SC) disability\nrecognizing variations in musculoskeletal development and appearance\nconsidering notable congenital or developmental defects\n, and\nchanges in the rating schedule\n.\nChange Date\nFebruary 8, 2021\nV.iii.1.F.1.a\n.\nSC for Fractures\nDecision makers must not automatically award service connection (SC) for fracture or fracture residuals based on a mere service treatment record (STR) reference to a fracture.\nWhere SC of a fracture or fracture residuals is\nclaimed\n, SC will be established when sufficient evidence, such as x-rays, a surgical report, casting, or a physical evaluation board report, documents the fracture.\nIf SC of a fracture has not been claimed and objective evidence such as x-ray report documents an in-service fracture, invite a claim for SC for the fracture.\nThe following considerations apply when granting SC for a fracture:\nSC will be established for a healed fracture even without current residual limited motion or functional impairment of a joint.\nAssign a diagnostic code (DC) consistent with the location of the fracture.  The fracture will be rated as noncompensable in the absence of any disabling manifestations.\nReference\n:  For more information on unclaimed chronic disabilities found in STRs, see\nM21-1, Part II, Subpart iii, 2.G.2\n.\nV.iii.1.F.1.b\n.\nSC for Osteopenia\nOsteopenia is clinically defined as mild bone density loss that is often associated with the normal aging process.  Low bone density does not necessarily mean that an individual is losing bone, as this may be a normal variant.\nOsteopenia is comparable to a laboratory finding which is not subject to service-connected (SC) compensation.\nUse the table below to determine the appropriate action to take when SC for osteopenia has been granted.\nIf ...\nThen ...\nSC for osteopenia was granted by rating decision dated\nprior to\nDecember 19, 2013 (the date on which guidance was issued to clarify the proper procedures for considering SC for osteopenia)\ndo not sever SC, as it was properly established based on guidance available at the time the decision was made,\ndo not reduce the previously assigned evaluation unless the condition has improved, and\nconsider claims for increased evaluation and schedule examination as warranted based on the facts of the case.\nNote\n:  Provisions of\n38 CFR 3.951\nand\n38 CFR 3.957\nregarding protection of SC remain applicable.\nSC for osteopenia was granted by rating decision dated\non or\nafter\nDecember 19, 2013\npropose to sever SC based on a finding of clear and unmistakable error.\nNote\n:  Osteoporosis, in contrast to osteopenia, is considered a disease entity characterized by severe bone loss that may interfere with mechanical support, structure, and function of the bone. SC for osteoporosis under\n38 CFR 4.71a, DC 5013\nis warranted when the requirements are otherwise met.\nV.iii.1.F.1.c\n.\nEvaluating Fibromyalgia\nThe criteria for evaluation of fibromyalgia under\n38 CFR 4.71a, DC 5025\ndoes not exclude assignment of separate evaluations when disabilities are diagnosed secondary to fibromyalgia.  This includes, but is not limited to, disability diagnoses for which symptoms are included in the evaluation criteria under\n38 CFR 4.71a, DC 5025\n, such as\ndepression\nanxiety\nheadache, and\nirritable bowel syndrome.\nNotes\n:\nIf signs and symptoms are not sufficient to warrant a diagnosis of a separate condition, then they are evaluated with the musculoskeletal pain and tender points under\n38 CFR 4.71a, DC 5025\n.\nWidespread musculoskeletal pain characteristic of fibromyalgia does not warrant assignment of separate evaluations for affected joints when only fibromyalgia is diagnosed.\nCo-existing, diagnosed musculoskeletal disabilities are evaluated separately.\nThe same signs and symptoms cannot be used to assign separate evaluations under different DCs, per\n38 CFR 4.14\n.\nWidespread musculoskeletal pain associated with fibromyalgia is not necessarily synonymous with painful motion of joint or periarticular pathology.\nAssignment of a compensable evaluation under\n38 CFR 4.71a, DC 5025\nfor fibromyalgia with widespread musculoskeletal pain does not prevent assignment of a compensable evaluation under\n38 CFR 4.59\nfor a separately diagnosed disability associated with painful motion of joint or periarticular pathology.\nReferences\n:  For more information on\nevaluating chronic pain syndrome (somatic symptom disorder), see\nM21-1, Part V, Subpart iii, 13.1.i\n, and\nevaluating co-existing fibromyalgia and mental disorders, see\nM21-1, Part V, Subpart iii, 13.1.h\n.\nV.iii.1.F.1.d\n.\nConsidering Conflicting Decisions Regarding LOU of an Extremity\nForward the claims folder to Compensation Service, for an advisory opinion under\nM21-1, Part X, Subpart v, 1.A.2\nto resolve a conflict if\nthe Insurance Center determines loss of use (LOU) of two extremities prior to rating consideration involving the same issue, and\nthe determination conflicts with the proposed rating decision.\nNote\n:  This issue will generally be brought to the attention of the rating activity as a result of the type of personal injury, correspondence, or some indication in the claims folder that the insurance activity is involved.\nV.iii.1.F.1.e\n.\nApplying the Amputation Rule\nThe combined evaluation for disabilities of an extremity shall not exceed the evaluation for the amputation at the elective level, were amputation to be performed.  The amputation rule is included in the musculoskeletal section of the rating schedule and, consequently, applies only to musculoskeletal disabilities and not to disabilities affecting other body systems.\nNotes\n:\nAny peripheral nerve injury associated with the musculoskeletal injury will be considered when applying the amputation rule.\nActual amputation with associated painful neuroma will be evaluated at the next-higher site of elective reamputation.\nThe amputation rule does not apply to evaluations of peripheral nerve disabilities of the extremities including, but not limited to, diabetic neuropathy, radiculopathy/sciatica due to a spinal disorder, or peripheral nerve injuries of non-musculoskeletal etiology.\nThe amputation rule does not apply to bilateral evaluations assigned under single DCs found in\n38 CFR 4.71a\n, such as those assigned for bilateral foot disabilities,\nexcept\nwhen being compared to a bilateral amputation of the same extremities.\nReferences\n:  For more information on the\namputation rule, see\n38 CFR 4.68\n, and\nMoyer v. Derwinski\n, 2 Vet.App. 289 (1992)\napplication of the amputation rule to rating decisions for osteomyelitis, see\nM21-1, Part V, Subpart iii, 1.D.1.g\napplication of the amputation rule to rating decisions for muscle injuries, see\nM21-1, Part V, Subpart iii, 1.E.2.j\n, and\nVeterans Benefits Management System – Rating (VBMS-R) amputation rule instructions, see the\nVBMS Job Aid – Amputation Rule for VBMS-R\n.\nV.iii.1.F.1.f\n.\nNSC Amputation Eliminating a Distal SC Disability\nFor guidance on disability evaluation considerations when an non-service-connected (NSC) disability results in amputation that eliminates a distal SC disability, see\nM21-1, Part V, Subpart ii, 3.D.5.c\n.\nV.iii.1.F.1.g\n.\nRecognizing Variations in Musculoskeletal Development and Appearance\nIndividuals vary greatly in their musculoskeletal development and appearance.  Functional variations are often seen and can be attributed to\nthe type of individual, and\nhis/her inherited or congenital variations from the normal.\nV.iii.1.F.1.h\n.\nConsidering Notable Congenital or Developmental Defects\nGive careful attention to congenital or developmental defects such as\nabsence of parts\nsubluxation (partial dislocation of a joint)\ndeformity or exostosis (bony overgrowth) of parts, and/or\naccessory or supernumerary (in excess of the normal number) parts.\nNote congenital defects of the spine, especially\nspondylolysis\nspina bifida\nunstable or exaggerated lumbosacral joints or angle, or\nincomplete sacralization.\nNotes\n:\nDo not automatically classify spondylolisthesis as a congenital condition, although it is commonly associated with a congenital defect.\nDo not automatically classify joint subluxation as a developmental or congenital condition.\nDo not overlook congenital diastasis of the rectus abdominus, hernia of the diaphragm, and the various myotonias.\nReferences\n:  For more information on\ncongenital or developmental defects, see\n38 CFR 4.9\n, and\nM21-1, Part V, Subpart ii, 2.E\n, and\nknee subluxation, see\nM21-1, Part V, Subpart iii, 1.B.4\n.\nV.iii.1.F.1.i\n.\nChanges in the Rating Schedule\nThe rating criteria for musculoskeletal disabilities have undergone revisions.  The most recent large-scale revisions were effective on February 7, 2021.\nNote\n:  These changes in rating criteria\nare not considered liberalizing, and\nshould not be the basis for a reduction in disability rating unless medical evidence establishes that the disability has actually improved.\nReferences\n:  For more information on the\nhistory of changes to the rating schedule for musculoskeletal disabilities\nthrough 2014, refer to the\nBoard of Veterans Appeals Research Tools\nwebsite for historical\n38 CFR 4.71a\n(or other applicable references)\nfrom 2015 and after, see the\nElectronic Code of Federal Regulations\nwebsite (using the browse feature for the date needed), and\nlisted by DC, see\n38 CFR Part 4, Appendix A\n, and\nprocedures for rating musculoskeletal disabilities prior to the February 7, 2021, update to the rating schedule, see the attachment\nHistorical_M21-1III_iv_4_SecA_\n1-21-21.docx\n.\n<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014422\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section E - Muscle Injuries\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014422/M21-1-Part-V-Subpart-iii-Chapter-1-Section-E-Muscle-Injuries\">&lt;-- Previous Section</a>  <a articleid=\"554400000014461\" articlename=\"M21-1, Part V, Subpart iii, Chapter 2, Section A - Conditions of the Eyes\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014461/M21-1-Part-V-Subpart-iii-Chapter-2-Section-A-Conditions-of-the-Eyes\">Next Section --&gt;</a></span></span></p><h2 class=\"ng-scope\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a></h2><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">In This Section</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">This section contains the topic “<a href=\"#1\" target=\"_self\">Other Musculoskeletal Considerations</a>.”</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><h2 class=\"ng-scope\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">1<a id=\"1\" name=\"1\">.</a>  Other Musculoskeletal Considerations</span></span></h2><p class=\"ng-scope\"><br/><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></p><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains general guidance on evaluating musculoskeletal conditions, including</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">service connection (SC) for </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1a\" target=\"_self\">fractures</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1b\" target=\"_self\">osteopenia</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1c\" target=\"_self\">evaluating fibromyalgia</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1d\" target=\"_self\">considering conflicting decisions regarding loss of use (LOU) of an extremity</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1e\" target=\"_self\">applying the amputation rule</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1f\" target=\"_self\">non-service-connected (NSC) amputation eliminating a distal service-connected (SC) disability</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1g\" target=\"_self\">recognizing variations in musculoskeletal development and appearance</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1h\" target=\"_self\">considering notable congenital or developmental defects</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1i\" target=\"_self\">changes in the rating schedule</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></strong></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></td><td style=\"width: 516px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">February 8, 2021</span></span></span></span></p></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.1.F.1.a<a id=\"1a\" name=\"1a\">.</a>  SC for Fractures</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Decision makers must not automatically award service connection (SC) for fracture or fracture residuals based on a mere service treatment record (STR) reference to a fracture. </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Where SC of a fracture or fracture residuals is <em>claimed</em>, SC will be established when sufficient evidence, such as x-rays, a surgical report, casting, or a physical evaluation board report, documents the fracture. </span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">If SC of a fracture has not been claimed and objective evidence such as x-ray report documents an in-service fracture, invite a claim for SC for the fracture.</span></span></span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The following considerations apply when granting SC for a fracture:</span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">SC will be established for a healed fracture even without current residual limited motion or functional impairment of a joint. </span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Assign a diagnostic code (DC) consistent with the location of the fracture.  The fracture will be rated as noncompensable in the absence of any disabling manifestations. </span></span></span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on unclaimed chronic disabilities found in STRs, see <a articleid=\"554400000174879\" articlename=\"M21-1, Part II, Subpart iii, Chapter 2, Section G - Requests for Application and Claims Solicitation\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000174879/M21-1-Part-II-Subpart-iii-Chapter-2-Section-G-Requests-for-Application-and-Claims-Solicitation\">M21-1, Part II, Subpart iii, 2.G.2</a>.</span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.1.F.1.b<a id=\"1b\" name=\"1b\">.</a>  SC for Osteopenia</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Osteopenia is clinically defined as mild bone density loss that is often associated with the normal aging process.  Low bone density does not necessarily mean that an individual is losing bone, as this may be a normal variant.</span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Osteopenia is comparable to a laboratory finding which is not subject to service-connected (SC) compensation. </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Use the table below to determine the appropriate action to take when SC for osteopenia has been granted. </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides information to determine the appropriate action to take when SC for osteopenia has been granted. \" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>If ...</strong></span></span></span></span></div></th><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Then ...</strong></span></span></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">SC for osteopenia was granted by rating decision dated <em>prior to</em> December 19, 2013 (the date on which guidance was issued to clarify the proper procedures for considering SC for osteopenia)</span></span></span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">do not sever SC, as it was properly established based on guidance available at the time the decision was made,</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">do not reduce the previously assigned evaluation unless the condition has improved, and</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">consider claims for increased evaluation and schedule examination as warranted based on the facts of the case.<span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></span></span></span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  Provisions of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=5d7de5e656ff0106cfa08aac437b09ea&amp;node=se38.1.3_1951&amp;rgn=div8\" target=\"_blank\">38 CFR 3.951</a> and <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=6a17e9b586e8acade155c1b03f427778&amp;node=se38.1.3_1957&amp;rgn=div8\" target=\"_blank\">38 CFR 3.957</a> regarding protection of SC remain applicable.</span></span></span></span></div></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">SC for osteopenia was granted by rating decision dated <em>on or</em> <em>after </em>December 19, 2013</span></span></span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">propose to sever SC based on a finding of clear and unmistakable error.</span></span></span></span></div></td></tr></tbody></table><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  Osteoporosis, in contrast to osteopenia, is considered a disease entity characterized by severe bone loss that may interfere with mechanical support, structure, and function of the bone. SC for osteoporosis under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=bb3684f1b5f15390c87a9d0a6b45dffc&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5013</a> is warranted when the requirements are otherwise met.</span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.1.F.1.c<a id=\"1c\" name=\"1c\">.</a>  Evaluating Fibromyalgia</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The criteria for evaluation of fibromyalgia under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c91c526668ff77d740cdc2572fcd55e5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5025</a> does not exclude assignment of separate evaluations when disabilities are diagnosed secondary to fibromyalgia.  This includes, but is not limited to, disability diagnoses for which symptoms are included in the evaluation criteria under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c91c526668ff77d740cdc2572fcd55e5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5025</a>, such as</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">depression</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">anxiety</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">headache, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">irritable bowel syndrome.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>: </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If signs and symptoms are not sufficient to warrant a diagnosis of a separate condition, then they are evaluated with the musculoskeletal pain and tender points under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c91c526668ff77d740cdc2572fcd55e5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5025</a>.</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Widespread musculoskeletal pain characteristic of fibromyalgia does not warrant assignment of separate evaluations for affected joints when only fibromyalgia is diagnosed.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Co-existing, diagnosed musculoskeletal disabilities are evaluated separately.</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The same signs and symptoms cannot be used to assign separate evaluations under different DCs, per <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c91c526668ff77d740cdc2572fcd55e5&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a>.  </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Widespread musculoskeletal pain associated with fibromyalgia is not necessarily synonymous with painful motion of joint or periarticular pathology.</span></span></div></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Assignment of a compensable evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c91c526668ff77d740cdc2572fcd55e5&amp;node=se38.1.4_171a&amp;rgn=div8\">38 CFR 4.71a, DC 5025</a> for fibromyalgia with widespread musculoskeletal pain does not prevent assignment of a compensable evaluation under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=479cd764fce07184ffb141a317f8d961&amp;mc=true&amp;node=se38.1.4_159&amp;rgn=div8\">38 CFR 4.59</a> for a separately diagnosed disability associated with painful motion of joint or periarticular pathology.</span></span></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating chronic pain syndrome (somatic symptom disorder), see <a articleid=\"554400000180520\" articlename=\"M21-1, Part V, Subpart iii, Chapter 13 - Mental Disorders\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180520/M21-1-Part-V-Subpart-iii-Chapter-13-Mental-Disorders\">M21-1, Part V, Subpart iii, 13.1.i</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating co-existing fibromyalgia and mental disorders, see <a articleid=\"554400000180520\" articlename=\"M21-1, Part V, Subpart iii, Chapter 13 - Mental Disorders\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180520/M21-1-Part-V-Subpart-iii-Chapter-13-Mental-Disorders\">M21-1, Part V, Subpart iii, 13.1.h</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.1.F.1.d<a id=\"1d\" name=\"1d\">.</a>  Considering Conflicting Decisions Regarding LOU of an Extremity</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Forward the claims folder to Compensation Service, for an advisory opinion under <a articleid=\"554400000177996\" articlename=\"M21-1, Part X, Subpart v, Chapter 1, Section A  - Compensation Service and Pension and Fiduciary (P&amp;F) Service Guidance\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177996/M21-1-Part-X-Subpart-v-Chapter-1-Section-A-Compensation-Service-and-Pension-and-Fiduciary-PF-Service-Guidance\">M21-1, Part X, Subpart v, 1.A.2</a> to resolve a conflict if</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the Insurance Center determines loss of use (LOU) of two extremities prior to rating consideration involving the same issue, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the determination conflicts with the proposed rating decision.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  This issue will generally be brought to the attention of the rating activity as a result of the type of personal injury, correspondence, or some indication in the claims folder that the insurance activity is involved.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.1.F.1.e<a id=\"1e\" name=\"1e\">.</a>  Applying the Amputation Rule</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The combined evaluation for disabilities of an extremity shall not exceed the evaluation for the amputation at the elective level, were amputation to be performed.  The amputation rule is included in the musculoskeletal section of the rating schedule and, consequently, applies only to musculoskeletal disabilities and not to disabilities affecting other body systems.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>: </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Any peripheral nerve injury associated with the musculoskeletal injury will be considered when applying the amputation rule. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Actual amputation with associated painful neuroma will be evaluated at the next-higher site of elective reamputation.  </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The amputation rule does not apply to evaluations of peripheral nerve disabilities of the extremities including, but not limited to, diabetic neuropathy, radiculopathy/sciatica due to a spinal disorder, or peripheral nerve injuries of non-musculoskeletal etiology.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The amputation rule does not apply to bilateral evaluations assigned under single DCs found in <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=84fd5a137366ded77bb642e56e27843e&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a</a>, such as those assigned for bilateral foot disabilities, <strong><em>except </em></strong>when being compared to a bilateral amputation of the same extremities.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on the</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">amputation rule, see </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f69019960cbee531ea8c3733895b301c&amp;mc=true&amp;node=se38.1.4_168&amp;rgn=div8\" target=\"_blank\">38 CFR 4.68</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://vbaw.vba.va.gov/bl/21/advisory/CAVCDAD.htm#bmm\" target=\"_blank\"><em>Moyer v. Derwinski</em></a>, 2 Vet.App. 289 (1992)</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">application of the amputation rule to rating decisions for osteomyelitis, see <a articleid=\"554400000014418\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section D - Osteomyelitis\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014418/M21-1-Part-V-Subpart-iii-Chapter-1-Section-D-Osteomyelitis\">M21-1, Part V, Subpart iii, 1.D.1.g</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">application of the amputation rule to rating decisions for muscle injuries, see <a articleid=\"554400000014422\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section E - Muscle Injuries\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014422/M21-1-Part-V-Subpart-iii-Chapter-1-Section-E-Muscle-Injuries\">M21-1, Part V, Subpart iii, 1.E.2.j</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Veterans Benefits Management System – Rating (VBMS-R) amputation rule instructions, see the <a href=\"http://vbaw.vba.va.gov/VBMS/docs/VBMS_Job_Aid_Amputation_Rule_Job_Aid_082613_v_5_0.pdf\" target=\"_blank\">VBMS Job Aid – Amputation Rule for VBMS-R</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.1.F.1.f<a id=\"1f\" name=\"1f\">.</a>  NSC Amputation Eliminating a Distal SC Disability</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">For guidance on disability evaluation considerations when an non-service-connected (NSC) disability results in amputation that eliminates a distal SC disability, see <a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.5.c</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.F.1.g<a id=\"1g\" name=\"1g\">.</a>  Recognizing Variations in Musculoskeletal Development and Appearance</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Individuals vary greatly in their musculoskeletal development and appearance.  Functional variations are often seen and can be attributed to</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the type of individual, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">his/her inherited or congenital variations from the normal.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.F.1.h<a id=\"1h\" name=\"1h\">.</a>  Considering Notable Congenital or Developmental Defects</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Give careful attention to congenital or developmental defects such as</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">absence of parts</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">subluxation (partial dislocation of a joint)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">deformity or exostosis (bony overgrowth) of parts, and/or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">accessory or supernumerary (in excess of the normal number) parts.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Note congenital defects of the spine, especially</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">spondylolysis</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">spina bifida</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">unstable or exaggerated lumbosacral joints or angle, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">incomplete sacralization.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Notes</em></strong>: </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Do not automatically classify spondylolisthesis as a congenital condition, although it is commonly associated with a congenital defect.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Do not automatically classify joint subluxation as a developmental or congenital condition. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Do not overlook congenital diastasis of the rectus abdominus, hernia of the diaphragm, and the various myotonias.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">congenital or developmental defects, see </span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2c0fdf993dcb4d21745677a20d577163&amp;mc=true&amp;node=se38.1.4_19&amp;rgn=div8\" target=\"_blank\">38 CFR 4.9</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000180485\" articlename=\"M21-1, Part V, Subpart ii, Chapter 2, Section E - Service Connection (SC) for Congenital, Developmental, or Hereditary Disorders\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180485/M21-1-Part-V-Subpart-ii-Chapter-2-Section-E-Service-Connection-SC-for-Congenital-Developmental-or-Hereditary-Disorders\">M21-1, Part V, Subpart ii, 2.E</a>, and</span></span></li></ul></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">knee subluxation, see <a articleid=\"554400000014410\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section B - Musculoskeletal Disabilities of the Extremities and Spine\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014410/M21-1-Part-V-Subpart-iii-Chapter-1-Section-B-Musculoskeletal-Disabilities-of-the-Extremities-and-Spine\">M21-1, Part V, Subpart iii, 1.B.4</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.F.1.i<a id=\"1i\" name=\"1i\">.</a>  Changes in the Rating Schedule</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The rating criteria for musculoskeletal disabilities have undergone revisions.  The most recent large-scale revisions were effective on February 7, 2021.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  These changes in rating criteria</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">are not considered liberalizing, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">should not be the basis for a reduction in disability rating unless medical evidence establishes that the disability has actually improved.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on the</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">history of changes to the rating schedule for musculoskeletal disabilities</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">through 2014, refer to the <a href=\"http://vacoappbva2.dva.va.gov/lsa/cgi-bin/query-meta.exe?v%3aproject=lsa-bva-counsel-judge-project&amp;v%3asources=lsa-bva-citator-regulation-collection&amp;frontpage=1&amp;v%3aframe=form&amp;\" target=\"_blank\">Board of Veterans Appeals Research Tools</a> website for historical <a href=\"http://vacoappbva2.dva.va.gov/lsa/cgi-bin/query-meta.exe?v%3afile=viv_XB7BOF&amp;v%3astate=root%7croot&amp;url=file%3a%2f%2fvacoappbva2.dva.va.gov%2fdocuments%2fCitatorRegulation%2f4-71a.pdf&amp;rid=Ndoc0&amp;v%3aframe=redirect&amp;v%3aredirect-hash=2147bdc33b0171ecab11dfade70d802c&amp;\" target=\"_blank\">38 CFR 4.71a</a> (or other applicable references)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">from 2015 and after, see the <a href=\"https://www.ecfr.gov/cgi-bin/ECFR?SID=08925fb1f36fc8b57fd14361dbc7a3d7&amp;pitd=00000000&amp;page=browse\" target=\"_blank\"><em>Electronic Code of Federal Regulations</em></a> website (using the browse feature for the date needed), and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">listed by DC, see <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=9595cf41a967b3969db583cd87f48a34&amp;mc=true&amp;node=ap38.1.4_1150.a&amp;rgn=div9\" target=\"_blank\">38 CFR Part 4, Appendix A</a>, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">procedures for rating musculoskeletal disabilities prior to the February 7, 2021, update to the rating schedule, see the attachment <em>Historical_M21-1III_iv_4_SecA_</em><em>1-21-21.docx</em>.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014422\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section E - Muscle Injuries\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014422/M21-1-Part-V-Subpart-iii-Chapter-1-Section-E-Muscle-Injuries\">&lt;-- Previous Section</a>  <a articleid=\"554400000014461\" articlename=\"M21-1, Part V, Subpart iii, Chapter 2, Section A - Conditions of the Eyes\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014461/M21-1-Part-V-Subpart-iii-Chapter-2-Section-A-Conditions-of-the-Eyes\">Next Section --&gt;</a></span></span></p><p class=\"ng-scope\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#top\" target=\"_self\"><span style=\"font-size: 11px\">To Top</span></a></span></span></span></p><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://vacoappbva2.dva.va.gov/lsa/cgi-bin/query-meta.exe?v%3afile=viv_XB7BOF&v%3astate=root%7croot&url=file%3a%2f%2fvacoappbva2.dva.va.gov%2fdocuments%2fCitatorRegulation%2f4-71a.pdf&rid=Ndoc0&v%3aframe=redirect&v%3aredirect-hash=2147bdc33b0171ecab11dfade70d802c&",
    "http://vacoappbva2.dva.va.gov/lsa/cgi-bin/query-meta.exe?v%3aproject=lsa-bva-counsel-judge-project&v%3asources=lsa-bva-citator-regulation-collection&frontpage=1&v%3aframe=form&",
    "http://vbaw.vba.va.gov/VBMS/docs/VBMS_Job_Aid_Amputation_Rule_Job_Aid_082613_v_5_0.pdf",
    "http://vbaw.vba.va.gov/bl/21/advisory/CAVCDAD.htm#bmm",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=2c0fdf993dcb4d21745677a20d577163&mc=true&node=se38.1.4_19&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=5d7de5e656ff0106cfa08aac437b09ea&node=se38.1.3_1951&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=6a17e9b586e8acade155c1b03f427778&node=se38.1.3_1957&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=bb3684f1b5f15390c87a9d0a6b45dffc&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=c91c526668ff77d740cdc2572fcd55e5&node=se38.1.4_114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=c91c526668ff77d740cdc2572fcd55e5&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=f69019960cbee531ea8c3733895b301c&mc=true&node=se38.1.4_168&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/ECFR?SID=08925fb1f36fc8b57fd14361dbc7a3d7&pitd=00000000&page=browse",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=479cd764fce07184ffb141a317f8d961&mc=true&node=se38.1.4_159&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=84fd5a137366ded77bb642e56e27843e&mc=true&node=se38.1.4_171a&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=9595cf41a967b3969db583cd87f48a34&mc=true&node=ap38.1.4_1150.a&rgn=div9"
  ],
  "scraped_at": "2025-06-16T22:43:53.035366",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014461/M21-1-Part-V-Subpart-iii-Chapter-2-Section-A-Conditions-of-the-Eyes"
}